Scholars Central

Research articlePublished 31 Mar 2017

Photodynamic Therapy for Patients with Basal Cell Carcinoma: N.N. Alexandrov National Cancer Center Experience

Authors: Tzerkovsky DA

Archives of General Internal Medicine

Volume 1 · Issue 1 · Pages 22–24

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: In this study we present the retrospective analysis of photodynamic therapy with photosensitizer Photolon using the data obtained from 130 patients with basal cell carcinoma (T1N0M0, I stage). Methods and findings: The treatment was easily tolerated by the patients and high therapeutic and cosmetic effects were obtained after Photolon injection of 2-2.5 mg/kg and subsequent irradiation by the laser with wavelength 660 nm in light doses 50-200 J/cm2. Complete regression of primary and recurrence carcinomas was observed in 90.9% and 88.9%, respectively. In terms of the observation of 3 to 76 months of local tumor recurrence was detected in 7.7% of cases (n=10). Conclusion: Photodynamic therapy of basal cell carcinoma with Photolon can be recommended when there are complications with traditional treatment of the disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Archives of General Internal Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of General Internal Medicine
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Tzerkovsky DA”